Ralf A Linker (Ralf Linker)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Traumatic Brain Injury

Decision Making

Subarachnoid Hemorrhage

Magnetic Resonance

Top Venues

Therapeutic advances in neurological disorders

Journal of neurology

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Olaf Hoffmann, Ralf Gold, Sven G Meuth, Ralf A Linker, Thomas Skripuletz, Heinz Wiendl, Mike P Wattjes
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making? Therapeutic advances in neurological disorders 17 (2024)
Olaf Hoffmann, Ralf Gold, Sven G Meuth, Ralf A Linker, Thomas Skripuletz, Heinz Wiendl, Mike P Wattjes
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making? Therapeutic advances in neurological disorders 17 (2024)
Felix Heinrich, Isabell Cordts, Rene Günther, Benjamin Stolte, Daniel Zeller, Carsten Schröter, Ute Weyen, Martin Regensburger, Joachim Wolf, Ilka Schneider, Andreas Hermann, Moritz Metelmann, Zacharias Kohl, Ralf A Linker, Jan Christoph Koch, Florentine Radelfahr, Erik Schönfelder, Pavel Gardt, Tara Mohajer-Peseschkian, Alma Osmanovic, Thomas Klopstock, Johannes Dorst, Albert C Ludolph, Oliver Schöffski, Matthias Boentert, Tim Hagenacker, Marcus Deschauer, Paul Lingor, Susanne Petri, Olivia Schreiber-Katz
Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany. Journal of neurology (2023)
Sven Guenther Meuth, Antonios Bayas, Boris Kallmann, Ralf A Linker, Peter Rieckmann, Mike P Wattjes, Mathias Mäurer, Christoph Kleinschnitz
Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4. Expert opinion on pharmacotherapy 23 (13) (2022)
Stefanie Haase, Ralf A Linker
Inflammation in multiple sclerosis. Therapeutic advances in neurological disorders 14 (2021)
Konstantin Huhn, Peter Linz, Franziska Pemsel, Bernhard Michalke, Stefan Seyferth, Christoph Kopp, Mohammad Anwar Chaudri, Veit Rothhammer, Arnd Dörfler, Michael Uder, Armin Michael Nagel, Dominik N Muller, Anne Waschbisch, De-Hyung Lee, Tobias Bäuerle, Ralf A Linker, Stefanie Haase
Skin sodium is increased in male patients with multiple sclerosis and related animal models. Proceedings of the National Academy of Sciences of the United States of America 118 (28) (2021)
Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuss, Ralf A Linker, Mathias Mäurer, Orhan Aktas, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czaplinski, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Hans-Peter Hartung, Hans-Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I Leussink, Fritz Leutmezer, Volker Limmroth, Jan D Lünemann, Andreas Lutterotti, Sven G Meuth, Uta Meyding-Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S Weber, Uwe K Zettl, Tjalf Ziemssen, Frauke Zipp, null null
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic advances in neurological disorders 14 (2021)
Elisabeth Bumes, Fro-Philip Wirtz, Claudia Fellner, Jirka Grosse, Dirk Hellwig, Peter J Oefner, Martina Häckl, Ralf A Linker, Martin Proescholdt, Nils Ole Schmidt, Markus J Riemenschneider, Claudia Samol, Katharina Rosengarth, Christina Wendl, Peter Hau, Wolfram Gronwald, Markus Hutterer
Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning. Cancers 12 (11) (2020)
Mathias Mäurer, Klaus Tiel-Wilck, Eckard Oehm, Nils Richter, Michael Springer, Patrick Oschmann, Arndt Manzel, Stefanie Hieke-Schulz, Vera Zingler, Julia A Kandenwein, Tjalf Ziemssen, Ralf A Linker
Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis. Therapeutic advances in neurological disorders 12 (2019)